The first stop for professional medicines advice

Medicines planning

40 results

Applied filters

Costing Clinical Trials of ATIMPs using the NIHR iCT - Advice for Pharmacy Sites

12 July 2022Guidance to support and promote consistent pharmacy costing for commercial clinical trials involving ATIMPs.

Good governance when implementing tocilizumab biosimilar

5 March 2024Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring, and pharmacovigilance.

Planning

We support organisations with the planned introduction of medicines. We create annual review products as well as ongoing updates to keep you informed.

Preparing to use ranibizumab biosimilar

29 June 2022Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team

The licence and supporting evidence for eculizumab biosimilars

6 March 2024Two licensed eculizumab biosimilars are available: Bekemv and Epysqli. Learn about the licensed indications, supporting evidence and key differences.

Good governance when implementing natalizumab biosimilar

6 February 2024Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring and pharmacovigilance.

Biosimilar and key generic medicines - April 2025 update

9 April 2025An update supporting implementation of biosimilar and key generic medicines for aflibercept, golimumab, nilotinib and ferric carboxymaltose.

New Medicines News

5 January 2023

Preparing to use golimumab biosimilar

21 May 2025Golimumab biosimilars are expected soon. We offer general information and implementation advice.

National Homecare Medicines Committee (NHMC) Managing Complaints and Incidents within Homecare Services - Appendix 19 training

2 July 2018In November 2016, the Royal Pharmaceutical Society (RPS) published Appendix 19 of the Royal Pharmaceutical Society (RPS) Handbook for Homecare Services in England i.e. ‘Further…